Skip to main content

Table 3 2009 Price comparison and market share of SEB Epoetins in five European countries [38],[40]

From: Potential impact of subsequent entry biologics in nephrology practice in Canada

  Germany UK France Italy Spain
Year of 1 st SEB introduced 2007 2008 2008 2008 2009
Number of SEB epoetins on market 4 1 1 3 2
SEB market share (sales as%) 53 0.95 2.97 0.29 2.91
Price innovator vs SEB (€/ddd)* 9.3 vs. 6.5 9.5 vs. 7.8 11.4 vs. 7.4 9.5 vs.7.8 8.5 vs. 6.5
Average price difference between innovator epoetin and SEB (%) 43 22 54 22 32
  1. *€/ddd = Euros per defined daily dose. The WHO has defined the ddd for Epoetin to be 1,000 international units per day.